Induction of cytochrome P450 3A by retinoids in rat hepatocyte culture

被引:18
作者
JurimaRomet, M
Neigh, S
Casley, WL
机构
[1] Bureau of Drug Research, Drugs Directorate, Health Canada, Ottawa, Ontario
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1997年 / 16卷 / 04期
关键词
cytochrome P450; retinoids; hepatocytes; rat;
D O I
10.1177/096032719701600407
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 Rat hepatocytes cultured on a Matrigel matrix were exposed for 48 h to all-trans-retinoic acid, 9-cis-retinoic acid, 13-cis-retinoic acid or fenretinide, 2 Cytochrome P450 3A (CYP3A) RNA levels were increased by approximately eightfold in hepatocytes treated with the retinoids compared to control cultures. 3 CYP1A1 and CYP1A2 RNA levels were only slightly affected or unaffected by the retinoids. 4 The induction of CYP3A by these therapeutically-useful retinoids suggests that they may share a common mechanism for accelerated drug catabolism and acquired clinical resistance.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 41 条
[1]   LIAROZOLE POTENTIATES THE CANCER CHEMOPREVENTIVE ACTIVITY OF AND THE UP-REGULATION OF GAP JUNCTIONAL COMMUNICATION AND CONNEXIN43 EXPRESSION BY RETINOIC ACID AND BETA-CAROTENE IN 10T1/2 CELLS [J].
ACEVEDO, P ;
BERTRAM, JS .
CARCINOGENESIS, 1995, 16 (09) :2215-2222
[2]  
BENNER SE, 1994, SEMIN HEMATOL, V31, pS26
[3]   GENBANK [J].
BENSON, DA ;
BOGUSKI, M ;
LIPMAN, DJ ;
OSTELL, J .
NUCLEIC ACIDS RESEARCH, 1994, 22 (17) :3441-3444
[4]   CYTOCHROME-P450 MAINTENANCE AND DIAZEPAM METABOLISM IN CULTURED RAT HEPATOCYTES [J].
BLANKSON, EA ;
CHENERY, RJ ;
PAINE, AJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (06) :1241-1245
[5]  
BOLLAG W, 1994, LEUKEMIA, V8, pS11
[6]   DIET AND LUNG-CANCER RISK - FINDINGS FROM THE WESTERN NEW-YORK DIET STUDY [J].
BYERS, TE ;
GRAHAM, S ;
HAUGHEY, BP ;
MARSHALL, JR ;
SWANSON, MK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 125 (03) :351-363
[7]  
CORREIA MA, 1995, CYTOCHROME P450 STRU, P607
[8]   INFLUENCE OF 13-CIS RETINOIC ACID AND OF AROTINOID ON THE CYTOCHROME-P-450 SYSTEM IN RAT-LIVER [J].
GOERZ, G ;
HAMM, L ;
BOLSEN, K ;
MERK, H .
DERMATOLOGICA, 1984, 168 (03) :117-121
[9]  
HONG WK, 1993, RETINOIDS ONCOLOGY
[10]  
HULTIN TA, 1988, DRUG METAB DISPOS, V16, P783